Oncologic Thermoradiotherapy: Need for Evidence, Harmonisation, and Innovation
The road of acceptance of oncologic thermotherapy/hyperthermia as a synergistic modality in combination with standard oncologic therapies is still bumpy. This is partially due to the lack of level I evidence from international, multicentric, randomized clinical trials including large patient numbers...
Đã lưu trong:
| Định dạng: | Online |
|---|---|
| Ngôn ngữ: | Tiếng Anh |
| Được phát hành: |
MDPI - Multidisciplinary Digital Publishing Institute
2022
|
| Những chủ đề: | |
| Truy cập trực tuyến: | ONIX_20220706_9783036545325_111 |
| Các nhãn: |
Không có thẻ, Là người đầu tiên thẻ bản ghi này!
|
| _version_ | 1869519358919704576 |
|---|---|
| collection | Directory of Open Access Books |
| description | The road of acceptance of oncologic thermotherapy/hyperthermia as a synergistic modality in combination with standard oncologic therapies is still bumpy. This is partially due to the lack of level I evidence from international, multicentric, randomized clinical trials including large patient numbers and a long term follow-up. Therefore we need more level I EVIDENCE from clinical trials, we need HARMONISATION and global acceptance for existing technologies and a common language understood by all stakeholders and we need INNOVATION in the fields of biology, clinics and technology to move thermotherapy/hyperthermia forward. This is the main focus of this reprint. In this reprintyou find carefully selected and peer-reviewed contributions from Africa, America, Asia, and Europe. The published papers from leading scientists from all over the world covering a broad range of timely research topics might also help to strengthen thermotherapy on a global level. |
| format | Online |
| id | doab-20.500.12854ir-87516 |
| institution | Directory of Open Access Books |
| language | eng |
| publishDate | 2022 |
| publishDateRange | 2022 |
| publishDateSort | 2022 |
| publisher | MDPI - Multidisciplinary Digital Publishing Institute |
| publisherStr | MDPI - Multidisciplinary Digital Publishing Institute |
| record_format | ojs |
| spelling | doab-20.500.12854ir-875162024-03-31T13:10:39Z Oncologic Thermoradiotherapy: Need for Evidence, Harmonisation, and Innovation Bodis, Stephan Ghadjar, Pirus Van Rhoon, Gerard C. perfusion estimation temperature monitoring conductivity reconstruction systems medicine immune system in silico perceptron antigen pattern danger signal fractionation immune response head and neck cancer hyperthermia reirradiation treatment outcome hyperthermia treatment planning adaptive planning temperature optimization low-middle-income group countries cancer radiotherapy chemotherapy recurrent breast cancers cervical cancer head and neck cancers cost-effective meta-analysis intensity-modulated radiotherapy prostate cancer thermal dose thermometric parameters preclinical data clinical evidence modulated electro-hyperthermia abscopal effect locally advanced cervical cancer resource-constrained setting radiosensitiser rectal cancer chemoradiotherapy tumour control loco-regional hyperthermia oncology cellular selection bioelectromagnetics complexity immune-effects moderate hyperthermia deep hyperthermia radiative hyperthermia patterns of care reimbursement regional hyperthermia neoadjuvant chemoradiation survival induced brachytherapy prostatic neoplasms interstitial hyperthermia treatment plan optimization prostate thermoradiotherapy linear quadratic model biological modeling thermal dosimetry hypoxia radiation therapy reoxygenation perfusion oxygen consumption rate local tumor control biomarker immune phenotype hyperthermia treatment sequence breast cancer immune checkpoint molecules dendritic cell activation n/a thema EDItEUR::M Medicine and Nursing thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCL Oncology The road of acceptance of oncologic thermotherapy/hyperthermia as a synergistic modality in combination with standard oncologic therapies is still bumpy. This is partially due to the lack of level I evidence from international, multicentric, randomized clinical trials including large patient numbers and a long term follow-up. Therefore we need more level I EVIDENCE from clinical trials, we need HARMONISATION and global acceptance for existing technologies and a common language understood by all stakeholders and we need INNOVATION in the fields of biology, clinics and technology to move thermotherapy/hyperthermia forward. This is the main focus of this reprint. In this reprintyou find carefully selected and peer-reviewed contributions from Africa, America, Asia, and Europe. The published papers from leading scientists from all over the world covering a broad range of timely research topics might also help to strengthen thermotherapy on a global level. 2022-07-06T11:54:01Z 2022-07-06T11:54:01Z 2022 book ONIX_20220706_9783036545325_111 9783036545325 9783036545318 https://directory.doabooks.org/handle/20.500.12854/87516 eng application/octet-stream Attribution 4.0 International https://mdpi.com/books/pdfview/book/5714 https://mdpi.com/books/pdfview/book/5714 MDPI - Multidisciplinary Digital Publishing Institute 10.3390/books978-3-0365-4531-8 10.3390/books978-3-0365-4531-8 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 9783036545325 9783036545318 346 Basel open access |
| spellingShingle | perfusion estimation temperature monitoring conductivity reconstruction systems medicine immune system in silico perceptron antigen pattern danger signal fractionation immune response head and neck cancer hyperthermia reirradiation treatment outcome hyperthermia treatment planning adaptive planning temperature optimization low-middle-income group countries cancer radiotherapy chemotherapy recurrent breast cancers cervical cancer head and neck cancers cost-effective meta-analysis intensity-modulated radiotherapy prostate cancer thermal dose thermometric parameters preclinical data clinical evidence modulated electro-hyperthermia abscopal effect locally advanced cervical cancer resource-constrained setting radiosensitiser rectal cancer chemoradiotherapy tumour control loco-regional hyperthermia oncology cellular selection bioelectromagnetics complexity immune-effects moderate hyperthermia deep hyperthermia radiative hyperthermia patterns of care reimbursement regional hyperthermia neoadjuvant chemoradiation survival induced brachytherapy prostatic neoplasms interstitial hyperthermia treatment plan optimization prostate thermoradiotherapy linear quadratic model biological modeling thermal dosimetry hypoxia radiation therapy reoxygenation perfusion oxygen consumption rate local tumor control biomarker immune phenotype hyperthermia treatment sequence breast cancer immune checkpoint molecules dendritic cell activation n/a thema EDItEUR::M Medicine and Nursing thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCL Oncology Oncologic Thermoradiotherapy: Need for Evidence, Harmonisation, and Innovation |
| title | Oncologic Thermoradiotherapy: Need for Evidence, Harmonisation, and Innovation |
| title_full | Oncologic Thermoradiotherapy: Need for Evidence, Harmonisation, and Innovation |
| title_fullStr | Oncologic Thermoradiotherapy: Need for Evidence, Harmonisation, and Innovation |
| title_full_unstemmed | Oncologic Thermoradiotherapy: Need for Evidence, Harmonisation, and Innovation |
| title_short | Oncologic Thermoradiotherapy: Need for Evidence, Harmonisation, and Innovation |
| title_sort | oncologic thermoradiotherapy need for evidence harmonisation and innovation |
| topic | perfusion estimation temperature monitoring conductivity reconstruction systems medicine immune system in silico perceptron antigen pattern danger signal fractionation immune response head and neck cancer hyperthermia reirradiation treatment outcome hyperthermia treatment planning adaptive planning temperature optimization low-middle-income group countries cancer radiotherapy chemotherapy recurrent breast cancers cervical cancer head and neck cancers cost-effective meta-analysis intensity-modulated radiotherapy prostate cancer thermal dose thermometric parameters preclinical data clinical evidence modulated electro-hyperthermia abscopal effect locally advanced cervical cancer resource-constrained setting radiosensitiser rectal cancer chemoradiotherapy tumour control loco-regional hyperthermia oncology cellular selection bioelectromagnetics complexity immune-effects moderate hyperthermia deep hyperthermia radiative hyperthermia patterns of care reimbursement regional hyperthermia neoadjuvant chemoradiation survival induced brachytherapy prostatic neoplasms interstitial hyperthermia treatment plan optimization prostate thermoradiotherapy linear quadratic model biological modeling thermal dosimetry hypoxia radiation therapy reoxygenation perfusion oxygen consumption rate local tumor control biomarker immune phenotype hyperthermia treatment sequence breast cancer immune checkpoint molecules dendritic cell activation n/a thema EDItEUR::M Medicine and Nursing thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCL Oncology |
| topic_facet | perfusion estimation temperature monitoring conductivity reconstruction systems medicine immune system in silico perceptron antigen pattern danger signal fractionation immune response head and neck cancer hyperthermia reirradiation treatment outcome hyperthermia treatment planning adaptive planning temperature optimization low-middle-income group countries cancer radiotherapy chemotherapy recurrent breast cancers cervical cancer head and neck cancers cost-effective meta-analysis intensity-modulated radiotherapy prostate cancer thermal dose thermometric parameters preclinical data clinical evidence modulated electro-hyperthermia abscopal effect locally advanced cervical cancer resource-constrained setting radiosensitiser rectal cancer chemoradiotherapy tumour control loco-regional hyperthermia oncology cellular selection bioelectromagnetics complexity immune-effects moderate hyperthermia deep hyperthermia radiative hyperthermia patterns of care reimbursement regional hyperthermia neoadjuvant chemoradiation survival induced brachytherapy prostatic neoplasms interstitial hyperthermia treatment plan optimization prostate thermoradiotherapy linear quadratic model biological modeling thermal dosimetry hypoxia radiation therapy reoxygenation perfusion oxygen consumption rate local tumor control biomarker immune phenotype hyperthermia treatment sequence breast cancer immune checkpoint molecules dendritic cell activation n/a thema EDItEUR::M Medicine and Nursing thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCL Oncology |
| url | ONIX_20220706_9783036545325_111 |